Magdalena Harrington - Pfizer, Inc | 人才画像

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure S3 from A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

Jeffrey Crawford,Roberto A. Calle,Susie M. Collins, Weihang Yan,Shannon L. Lubaczewski, Clare Buckeridge,Ellen Q. Wang,Magdalena Harrington,Anil Tarachandani,Michelle I. Rossulek,James H. Revkin

openalex

引用0浏览0引用

A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

Jeffrey Crawford,Roberto A. Calle,Susie M. Collins,Yan Weng,Shannon L. Lubaczewski, Clare Buckeridge,Ellen Q. Wang,Magdalena A. Harrington,Anil Tarachandani,Michelle I. Rossulek,James H. Revkin

CLINICAL CANCER RESEARCH（2024）

引用0浏览0WOS引用

Ponsegromab for the Treatment of Cancer Cachexia

John D Groarke,Jeffrey Crawford,Susie M Collins, Shannon Lubaczewski, Eric J Roeland,Tateaki Naito,Andrew E Hendifar,Marie Fallon, Koichi Takayama, Timothy Asmis,Richard F Dunne, Isik Karahanoglu, Carrie A Northcott,Magdalena A Harrington,Michelle Rossulek,Ruolun Qiu,Aditi R Saxena

The New England journal of medicine (2024)

引用0浏览0WOS引用

Phase 2 Study of the Efficacy and Safety of Ponsegromab in Patients with Cancer Cachexia: PROACC‐1 Study Design

John D. Groarke,Jeffrey Crawford,Susie M. Collins,Shannon L. Lubaczewski,Danna M. Breen,Magdalena A. Harrington,Ira Jacobs,Ruolun Qiu,James Revkin,Michelle I. Rossulek,Aditi R. Saxena

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLEno. 3 (2024): 1054-1061

引用0浏览0WOS引用

Abstract CT108: First-in-patient Study of the GDF-15 Inhibitor Ponsegromab in Patients with Cancer and Cachexia: Safety, Tolerability, and Exploratory Measures of Efficacy

Jeffrey Crawford,Roberto A. Calle,Susie M. Collins,Yan Weng,Shannon L. Lubaczewski, Clare Buckeridge,Ellen Q. Wang,Magdalena Harrington,Anil Tarachandani,Michelle I. Rossulek,James H. Revkin

Cancer researchno. 8_Supplement (2023): CT108-CT108

引用1浏览0引用

Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of the GDF-15 Inhibitor Ponsegromab in Patients with Cancer Cachexia

Jeffrey Crawford,Shannon L. Lubaczewski,Anil Tarachandani,Magdalena A. Harrington,Yan Weng,Ruolun Qiu,Susie M. Collins,Michelle I. Rossulek,James H. Revkin

Journal of Clinical Oncologyno. 16_suppl (2023): TPS12147-TPS12147

引用0浏览0引用

First-in-patient Study of the GDF-15 Inhibitor Ponsegromab in Patients with Cancer and Cachexia: Safety, Tolerability, and Exploratory Measures of Efficacy

Jeffrey Crawford,Roberto A. Calle,Susie M. Collins, Yan Weng,Shannon L. Lubaczewski, Clare Buckeridge,Ellen Q. Wang,Magdalena A. Harrington,Anil Tarachandani,Michelle I. Rossulek,James H. Revkin

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Abstract CT054: Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of the GDF-15 Inhibitor Ponsegromab in Patients with Cancer Cachexia

Jeffrey Crawford,Shannon Lubaczewski,Anil Tarachandani,Magdalena A. Harrington,Yan Weng,Ruolun Qiu,Susie M. Collins,Michelle I. Rossulek,James H. Revkin

Cancer Researchno. 8_Supplement (2023)

引用0浏览0引用

1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir Versus Placebo

Jennifer Hammond,Heidi Leister-Tebbe,Annie Gardner,Paula Abreu,Weihang Bao,Wayne Wisemandle,Wajeeha Ansari,Magdalena Alicja Harrington,Jesus Abraham Simón Campos,Kara W Chew,Rienk Pypstra,James M Rusnak

Open forum infectious diseasesno. Supplement_2 (2022)

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn